作者：
Li,Zhang [1]
;
Ngoc-Tung,Tran [1]
;
Hairui,Su [1]
;
Rui,Wang [2]
;
Yuheng,Lu [3]
;
Haiping,Tang [4]
;
Sayura,Aoyagi [5]
;
Ailan,Guo [5]
;
Alireza,Khodadadi-Jamayran [1]
;
Dewang,Zhou [1]
;
Kun,Qian [6]
;
Todd,Hricik [7]
;
Jocelyn,Côté [8]
;
Xiaosi,Han [9]
;
Wenping,Zhou [10]
;
Suparna,Laha [11]
;
Omar,Abdel-Wahab [7]
;
Ross L,Levine [7]
;
Glen,Raffel [11]
;
Yanyan,Liu [10]
;
Dongquan,Chen [12]
;
Haitao,Li [4]
;
Tim,Townes [1]
;
Hengbin,Wang [1]
;
Haiteng,Deng [4]
;
Y George,Zheng [6]
;
Christina,Leslie [3]
;
Minkui,Luo [2]
;
Xinyang,Zhao [1]
作者单位：
Department of Biochemistry and Molecular Genetics, UAB Stem Cell Institute, The University of Alabama at Birmingham, Birmingham, United States.
[1]
Program of Molecular Pharmacology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, United States.
[2]
Computational Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, United States.
[3]
School of Life Sciences, Tsinghua University, Beijing, China.
[4]
Cell Signaling Technology, Inc., Danvers, United States.
[5]
Department of Pharmaceutical and Biomedical Sciences, The University of Georgia, Athens, United States.
[6]
Human Oncology and Pathogenesis Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, United States.
[7]
Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada.
[8]
Department of Neurology, Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, United States.
[9]
Department of Internal Medicine, Zhengzhou - Henan Cancer Hospital, Zhengzhou, China.
[10]
Division of Hematology and Oncology, University of Massachusetts Medical School, Worcester, United States.
[11]
Division of Preventive Medicine, The University of Alabama at Birmingham, Birmingham, United States.
[12]
DOI
10.7554/eLife.07938
PMID
26575292
发布时间
2019-06-10
换一批
换一批
